Prolonged survival in a 57-year-old female with RB1-wildtype transformed small-cell lung cancer treated with immunochemotherapy and antiangiogenic combined therapy: a case report.

Kang L, Zhao L, Chen X, Kang N, Long P, Kang C, Li J, Zhang G

Open source

DOI
10.21037/acr-2026-0089
Published
2026
Container
AME case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/acr-2026-0089,
  title = {Prolonged survival in a 57-year-old female with RB1-wildtype transformed small-cell lung cancer treated with immunochemotherapy and antiangiogenic combined therapy: a case report.},
  author = {Kang L and Zhao L and Chen X and Kang N and Long P and Kang C and Li J and Zhang G},
  year = {2026},
  journal = {AME case reports},
  doi = {10.21037/acr-2026-0089},
  url = {https://doi.org/10.21037/acr-2026-0089}
}

RIS

TY  - JOUR
TI  - Prolonged survival in a 57-year-old female with RB1-wildtype transformed small-cell lung cancer treated with immunochemotherapy and antiangiogenic combined therapy: a case report.
AU  - Kang L
AU  - Zhao L
AU  - Chen X
AU  - Kang N
AU  - Long P
AU  - Kang C
AU  - Li J
AU  - Zhang G
PY  - 2026
JO  - AME case reports
DO  - 10.21037/acr-2026-0089
UR  - https://doi.org/10.21037/acr-2026-0089
ER  - 

APA

L, K., L, Z., X, C., N, K., P, L., C, K., J, L., & G, Z. (2026). Prolonged survival in a 57-year-old female with RB1-wildtype transformed small-cell lung cancer treated with immunochemotherapy and antiangiogenic combined therapy: a case report.. AME case reports. https://doi.org/10.21037/acr-2026-0089

Source records